Chakrapani Vemulawada

Chakrapani Vemulawada

Auto-generated profile, based on publicly available information

Chakrapani Vemulawada

Department of Pathology, University of Iowa Health Care , Iowa City

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
CVChakrapani Vemulawada
Chakrapani Vemulawada
PRPranav S. Renavikar
Pranav S. Renavikar
MCMichael P. Crawford
Michael P. Crawford
SSScott Steward-Tharp
Scott Steward-Tharp
NKNitin J. Karandikar
Nitin J. Karandikar
An imbalance between proinflammatory and regulatory processes underlies autoimmune disease pathogenesis. We have shown that acute relapses of multiple sclerosis are characterized by a deficit in the immune suppressive ability of CD8+ T cells. These cells play an important immune regulatory role, mediated in part through cytotoxicity (perforin [PRF]/granzyme [GZM]) and IFNγ secretion. In this study, we further investigated the importance of IFNγ–, GZMB-, PRF1-, and LYST-associated pathways in CD8+ T cell–mediated suppression. Using the CRISPR-Cas9 ribonucleoprotein transfection system, we first optimized efficient gene knockout while maintaining high viability in primary bulk human CD8+ T cells. Knockout was confirmed through quantitative real-time PCR assays in all cases, combined with flow cytometry where appropriate, as well as confirmation of insertions and/or deletions at genomic target sites. We observed that the knockout of IFNγ, GZMB, PRF1, or LYST, but not the knockout of IL4 or IL5, resulted in significantly diminished in vitro suppressive ability in these cells. Collectively, these results reveal a pivotal role for these pathways in CD8+ T cell–mediated immune suppression and provide important insights into the biology of human CD8+ T cell–mediated suppression that could be targeted for immunotherapeutic intervention.

16 July 2016 in Genes & Genomics
Verified
Journal Article
Closed access
PDF file
VCVemulawada Chakrapani
Vemulawada Chakrapani
SPSwagat K. Patra
Swagat K. Patra
SMShibani Mohapatra
Shibani Mohapatra
KRKiran D Rasal
Kiran D Rasal
UDUday Deshpande
Uday Deshpande
HBHirak K. Barman
Hirak K. Barman

5 November 2026 in ImmunoHorizons
Verified
Journal Article
Open access
KKKshitija Kale
Kshitija Kale
CVChakrapani Vemulawada
Chakrapani Vemulawada
KRKai Rogers
Kai Rogers
MCMichael P Crawford
Michael P Crawford
JHJace Heath
Jace Heath
NKNitin J Karandikar
Nitin J Karandikar
T helper 17 (Th17) CD4+ T cells are key mediators of autoimmune pathology. Interleukin (IL)-1β is a potent proinflammatory cytokine known to promote Th17 differentiation and pathogenicity, in combination with other cytokines. Whereas recent studies have shown that T cells are capable of expressing IL-1β themselves, the role of this T cell–endogenous IL-1β is poorly understood. Using CRISPR/Cas9-mediated deletion of IL1B in naïve human CD4+ T cells along with cytokine neutralization and IL-1 receptor blockade, we found that T cell–intrinsic IL-1β is not essential for Th17 differentiation or effector resistance. Remarkably, single-cell RNA sequencing revealed that IL1B deletion profoundly rewires the transcriptional and metabolic landscape within the T cells, suppressing glycolytic and hypoxia-responsive pathways. These findings uncouple T cell–intrinsic IL-1β from Th17 effector resistance while uncovering an important contribution toward sustaining metabolic roles. This refines our understanding of IL-1β biology and informs therapeutic strategies in immune-mediated disease settings.